BackDecibel Therapeutics Overview

Decibel Therapeutics Other Liabilities

Decibel Therapeutics's other liabilities is $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Decibel Therapeutics Other Liabilities History

Loading

Decibel Therapeutics vs. peers: Other Liabilities Comparison

Loading

Decibel Therapeutics Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Decibel Therapeutics (DBTX) FAQ

Decibel Therapeutics (DBTX) currently reports a other liabilities of $0 as of June 2023. In the prior-year period, the figure was $0. Use the charts on this page to explore Decibel Therapeutics's other liabilities history and peer comparisons.

Decibel Therapeutics's other liabilities changed from $0 to $0 (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Decibel Therapeutics reported $0 in other liabilities as of June 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Decibel Therapeutics, and consider following DBTX for alerts when major investors trade the stock.

Decibel Therapeutics is classified in the Healthcare sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DBTX with unrelated industries.